7358 related articles for article (PubMed ID: 17718062)
41. Who wants cancer screening with PET? A contingent valuation survey in Japan.
Yasunaga H
Eur J Radiol; 2009 Apr; 70(1):190-4. PubMed ID: 18093777
[TBL] [Abstract][Full Text] [Related]
42. Relationship of detection rate of PET cancer screening examinees and risk factors: analysis of background of examinees.
Shibata K; Arai M; Matsuura M; Uno K; Yoshida T; Momose T; Ohtomo K
Ann Nucl Med; 2011 May; 25(4):261-7. PubMed ID: 21188657
[TBL] [Abstract][Full Text] [Related]
43. Imaging and 'omic' methods for the molecular diagnosis of cancer.
Bohndiek SE; Brindle KM
Expert Rev Mol Diagn; 2010 May; 10(4):417-34. PubMed ID: 20465497
[TBL] [Abstract][Full Text] [Related]
44. Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies.
Pantel AR; Ackerman D; Lee SC; Mankoff DA; Gade TP
J Nucl Med; 2018 Sep; 59(9):1340-1349. PubMed ID: 30042161
[TBL] [Abstract][Full Text] [Related]
45. Cancer screening by FDG-PET: benefit or risk?
Hatazawa J
Ann Nucl Med; 2011 Nov; 25(9):667-8. PubMed ID: 21987285
[No Abstract] [Full Text] [Related]
46. [Epidemiological study on PET cancer screening].
Senda M; Inoue T; Uno K; Jinnouchi M; Tsukamoto E; Terauchi T; Nakajima R; Nishizawa S; Minamimoto R; Yoshida T
Kaku Igaku; 2009 Jun; 46(2):100-2. PubMed ID: 19791309
[No Abstract] [Full Text] [Related]
47. FDG-PET in breast cancer: a different view of its clinical usefulness.
Czernin J
Mol Imaging Biol; 2002 Jan; 4(1):35-45. PubMed ID: 14538047
[TBL] [Abstract][Full Text] [Related]
48. Mapping tissue heterogeneity in solid tumours using PET-MRI and machine learning.
Nat Biomed Eng; 2023 Aug; 7(8):969-970. PubMed ID: 37277484
[No Abstract] [Full Text] [Related]
49. Enhancement of immune reactivity in the lymph nodes draining a murine melanoma engineered to elaborate interleukin-4.
Krauss JC; Strome SE; Chang AE; Shu S
J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):77-84. PubMed ID: 7804530
[TBL] [Abstract][Full Text] [Related]
50. [An autopsy case of primary malignant melanoma of the ovary].
Fujiwara M; Nakamura T; Watanabe M; Hotchi M; Yokoo A; Tanizaki Y; Mizuno M; Saito T
Gan No Rinsho; 1985 Apr; 31(4):441-8. PubMed ID: 4009976
[TBL] [Abstract][Full Text] [Related]
51. Chemical composition and in vitro cytotoxic effects of the essential oil from Nectandra leucantha leaves.
Grecco Sdos S; Martins EG; Girola N; de Figueiredo CR; Matsuo AL; Soares MG; Bertoldo Bde C; Sartorelli P; Lago JH
Pharm Biol; 2015 Jan; 53(1):133-7. PubMed ID: 25339603
[TBL] [Abstract][Full Text] [Related]
52. Protective effect of trehalose-loaded liposomes against UVB-induced photodamage in human keratinocytes.
Emanuele E; Bertona M; Sanchis-Gomar F; Pareja-Galeano H; Lucia A
Biomed Rep; 2014 Sep; 2(5):755-759. PubMed ID: 25054023
[TBL] [Abstract][Full Text] [Related]
53. [Effects of excreted/secreted antigens of Toxoplasma gondii on CD4+ CD25+ Foxp3+ T cells and NK cells of melanoma-bearing mice].
Jiao YM; Zhang L; Ge YY; Liang YJ; Yong W
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):301-6. PubMed ID: 22164498
[TBL] [Abstract][Full Text] [Related]
54. Anti-Angiogenic/Vascular Effects of the mTOR Inhibitor Everolimus Are Not Detectable by FDG/FLT-PET.
Honer M; Ebenhan T; Allegrini PR; Ametamey SM; Becquet M; Cannet C; Lane HA; O'Reilly TM; Schubiger PA; Sticker-Jantscheff M; Stumm M; McSheehy PM
Transl Oncol; 2010 Aug; 3(4):264-75. PubMed ID: 20689768
[TBL] [Abstract][Full Text] [Related]
55. Dimethylfumarate inhibits tumor cell invasion and metastasis by suppressing the expression and activities of matrix metalloproteinases in melanoma cells.
Yamazoe Y; Tsubaki M; Matsuoka H; Satou T; Itoh T; Kusunoki T; Kidera Y; Tanimori Y; Shoji K; Nakamura H; Ogaki M; Nishiura S; Nishida S
Cell Biol Int; 2009 Oct; 33(10):1087-94. PubMed ID: 19595779
[TBL] [Abstract][Full Text] [Related]
56. [Tumor antigens recognized by T-lymphocytes in human cancers. New advances and therapeutic perspectives].
Gaugler B; Olive D
Pathol Biol (Paris); 1998 Dec; 46(10):771-8. PubMed ID: 9922993
[TBL] [Abstract][Full Text] [Related]
57. Classification of intestinal T-cell neoplasms and their differential diagnosis.
Chott A; Vesely M; Simonitsch I; Mosberger I; Hanak H
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S68-74. PubMed ID: 9894471
[TBL] [Abstract][Full Text] [Related]
58. Favourable melanoma prognosis associated with the expression of the tumour necrosis factor receptor and the alpha1beta1 integrin: a preliminary report.
Gilhar A; Ullmann Y; Kalish RS; Berkutski T; Azizi E; Bank I
Melanoma Res; 1997 Dec; 7(6):486-95. PubMed ID: 9464621
[TBL] [Abstract][Full Text] [Related]
59. Human epidermal melanocyte and keratinocyte melanotropin receptors: visualization by melanotropic peptide conjugated macrospheres (polyamide beads).
Jiang J; Sharma SD; Hruby VJ; Fink JL; Hadley ME
Exp Dermatol; 1997 Feb; 6(1):6-12. PubMed ID: 9067701
[TBL] [Abstract][Full Text] [Related]
60. Combinatorial effects of monoclonal anti-p120 antibody (MAbp120), liposomes and hyperthermia on MCF-7 and LOX tumor cell lines.
Perlaky L; Busch RK; Busch H
Oncol Res; 1996; 8(9):363-9. PubMed ID: 8979270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
